OGT Taps Kreatech to Distribute CytoSure Arrays in France

France is a "key market" for OGT, due in part to its "strong emphasis on health care," according to James Clough, vice president of clinical and genomic solutions at the UK-based company.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.